Detalhe da pesquisa
1.
The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure.
Breast Cancer Res Treat
; 153(1): 145-52, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26210520
2.
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers.
Br J Cancer
; 108(10): 2172-7, 2013 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23558900
3.
Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer.
Br J Cancer
; 109(12): 2965-72, 2013 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149178
4.
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.
Ann Oncol
; 24(2): 537-542, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23117071
5.
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response.
Breast Cancer Res Treat
; 140(1): 63-71, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23828499
6.
Clinical correlates of 'BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapy.
Ann Oncol
; 23(9): 2301-2305, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22357256
7.
Neoadjuvant chemotherapy in ER+ HER2- breast cancer: response prediction based on immunohistochemical and molecular characteristics.
Breast Cancer Res Treat
; 131(3): 827-36, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21472434
8.
Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 39(12): 1830-8, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895862
9.
Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.
Ann Oncol
; 22(4): 870-876, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20937646
10.
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.
Ann Oncol
; 22(7): 1561-1570, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135055
11.
A simple system for grading the response of breast cancer to neoadjuvant chemotherapy.
Ann Oncol
; 21(3): 481-487, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19717533
12.
The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.
Ann Surg Oncol
; 17(9): 2411-8, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20373039
13.
Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
Bone Marrow Transplant
; 42(7): 475-81, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18622420
14.
[Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]. / Neoadjuvante systemische therapie bij het primair operabel mammacarcinoom: meer voordelen dan alleen borstsparende behandeling.
Ned Tijdschr Geneeskd
; 152(46): 2519-25, 2008 Nov 15.
Artigo
em Holandês
| MEDLINE | ID: mdl-19055260
15.
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
J Clin Invest
; 93(2): 516-20, 1994 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-7906694
16.
PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.
Eur J Surg Oncol
; 43(4): 625-635, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27847287
17.
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial.
J Clin Oncol
; 23(3): 576-84, 2005 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15659504
18.
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.
J Natl Cancer Inst
; 83(14): 1024-7, 1991 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-2072410
19.
Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
J Natl Cancer Inst
; 90(3): 210-8, 1998 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-9462678
20.
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer.
J Natl Cancer Inst
; 82(17): 1416-20, 1990 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-2388293